In Vitro Eye Irritation: Ocular Safety Assessment Without the Use of Animals

The eye is one of the body’s most sensitive organs to chemicals. The cornea, iris, and conjunctiva can sustain irreversible damage as a result of chemical exposure. Therefore, determining the potential for ocular irritation and corrosion of chemicals, mixtures, and medical device extracts is essential for GHS classification and user safety. In vitro eye irritation tests enable this assessment to be conducted without the use of animals, using validated methods and in accordance with international standards.

Our laboratory offers four OECD-validated methods (TG 491, TG 492, TG 437, and TG 438) in accordance with GLP principles. By combining these methods within the framework of a stepwise testing strategy and defined approaches (Defined Approach – DA), the need for the in vivo Draize test can be largely eliminated.

Why In Vitro Eye Irritation?

The traditional in vivo Draize test (OECD TG 405) has long been criticized for causing severe animal suffering and relying on subjective scoring. In contrast, in vitro methods are ethically superior because they use human cells or slaughterhouse by-product tissues; they offer high reproducibility and allow for more direct extrapolation to human biology. The OECD recognizes these methods as the primary step in a tiered testing strategy, positioning the in vivo test only as a last resort.

In vitro tests also hold significant regulatory value. Data obtained through these methods are valid under the EU REACH Regulation, the CLP Regulation, the EU Cosmetics Regulation (EC 1223/2009), and Turkey’s KKDIK. Since animal testing is prohibited in the EU, particularly for cosmetic products, in vitro methods are the only mandatory option.

Four Validated Methods

OECD TG 491 (STE – Short-Term Exposure) is an in vitro test performed using a human corneal epithelial cell line. The test substance is applied to the cells for a short period, and cell viability is measured using the MTT assay. It provides a rapid and economical screening method for water-soluble substances; it is typically used as part of a defined approach.

OECD TG 492 (RhCE – Reconstituted Human Corneal-Like Epithelium) uses three-dimensional tissue models that mimic human corneal epithelium. The test substance is applied to the tissue, and cell viability is measured using the MTT assay. It is the primary method for cosmetics and personal care products; it distinguishes between “Not Subject to Classification” and “Irritant.”

OECD TG 437 (BCOP – Bovine Corneal Opacity and Permeability) is an ex vivo test that uses bovine corneas obtained from slaughterhouses. By measuring corneal opacity and permeability, an in vitro irritation score is calculated. It is suitable for a wide range of substances, including water-insoluble ones, and provides high accuracy in identifying “Serious Eye Damage” (Category 1).

OECD TG 438 (ICE – Isolated Chicken Eye) is an ex vivo test that uses eyes obtained from chickens slaughtered for food consumption. Corneal opacity, fluorescein retention, increases in corneal thickness, and morphological damage are evaluated. It is effective for surfactants and alcohol-based products.

The table below provides a comparative summary of the key characteristics of the four methods.

Comparison of In Vitro Eye Irritation Methods
Characteristic TG 491 (STE) TG 492 (RhCE) TG 437 (BCOP) TG 438 (ICE)
Test System Human corneal epithelial cell line Three-dimensional human corneal epithelial model Bovine cornea (ex vivo) Chicken eye (ex vivo)
Measurement Parameter Cell viability (MTT) Cell viability (MTT) Opacity + permeability Opacity, fluorescein, swelling, morphology
Classification Capability Limited (DA component) Not Subject to Classification / Irritant Category 1 and Not Subject to Classification Category 1 and Not Subject to Classification
Suitable Test Substances Water-soluble substances Cosmetics, water-soluble substances Liquid, solid, paste; including water-insoluble substances Surfactants, alcohols
3R Compliance Full Full Full (slaughterhouse by-product) Full (slaughterhouse by-product)

Integrated Testing Strategy

The OECD has developed Defined Approaches (DA) for cases where a single in vitro test is insufficient for eye irritation assessment. These approaches, adopted under OECD TG 467, aim to reduce or eliminate the need for in vivo testing by combining the results of different in vitro tests. DAL-1 and DAL-2 have been defined for liquids, DAS for solids, and DASF for surfactants.

The first step in the testing strategy is the evaluation of the substance’s physicochemical properties. Substances with a pH value ≤2 or ≥11.5 are directly classified as “Serious Eye Damage” (Category 1) under the tiered strategy, and in vitro testing is not required. This approach prevents unnecessary testing and ensures the efficient use of resources. For substances with a pH value outside this range, the appropriate DA combination is selected based on the substance’s physical form and solubility.

GHS classification results are evaluated in three categories. Category 1 (Serious Eye Damage / Corrosive) is labeled with the statement “Causes serious eye damage” (H318) and the GHS05 pictogram. Category 2A (Eye Irritant) is labeled with the statement “Causes serious eye irritation” (H319) and the GHS07 pictogram. Category 2B (Mild Irritant), on the other hand, covers temporary effects that resolve completely within 7 days and is not used in some regulations.

Frequently Asked Questions

Which method is appropriate for my product? Method selection depends on the product’s physical form, solubility, and regulatory objective. TG 492 or TG 491 may be suitable for water-soluble liquids; TG 437 for water-insoluble substances; and TG 438 for surfactants. In most cases, DA combinations are preferred over a single test. Our laboratory recommends the most appropriate strategy based on your product’s characteristics.

Is testing required for substances with extreme pH values? No. Substances with a pH ≤2 or ≥11.5 are directly classified as Category 1 under the OECD tiered strategy, and in vitro testing is not required.

Do in vitro results substitute for in vivo testing? Validated in vitro methods and DA’s allow for classification without the need for in vivo testing. The OECD and EU REACH recognize these methods as primary tests. In cases where results are uncertain or when specifically requested by the regulatory authority, in vivo validation may be required.

For which regulatory submissions can these methods be used? Applicable for TG 491, 492, 437, and 438 reports; EU REACH, CLP Regulation, GHS classification, EU Cosmetics Regulation, U.S. EPA FIFRA, and Turkish KKDIK requirements.

Contact our laboratory to evaluate your product’s ocular safety profile using validated in vitro methods, in accordance with GLP standards, and without the need for animal testing. Our team of experts will determine a testing strategy tailored to your product, thereby accelerating your regulatory process.

EnglishenEnglishEnglish